Roisin Connon
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda.
Journal: The New England journal of medicine
Published: June 03, 2026
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD-CAA prevention (KD-CAAP) trial.
Journal: EClinicalMedicine
Published: March 02, 2026
Oral rehydration for severe malnutrition in children with moderate and severe dehydration (GASTROSAM): a phase 2, open-label, superiority randomised controlled trial.
Journal: The Lancet. Child & adolescent health
Published: September 05, 2025
Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis.
Journal: The New England journal of medicine
Published: June 13, 2025
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).
Journal: Wellcome open research
Published: August 07, 2024
A Phase I trial of Non-invasive Ventilation and seizure prophylaxis with levetiracetam In Children with Cerebral Malaria Trial (NOVICE-M Trial).
Journal: Wellcome open research
Published: April 24, 2024
Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trial.
Journal: BMC medicine
Published: February 13, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.
Journal: ERJ open research
Published: July 24, 2023
Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa.
Journal: Nature communications
Published: May 15, 2023
Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled trial.
Journal: Wellcome open research
Published: December 19, 2022
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
Journal: Trials
Published: October 28, 2022
Last Updated: 09/26/2026